Modulation of hydrogen peroxide-induced DNA damage, MAPKs activation and cell death in PC12 by ergothioneine

Clinical Nutrition

Volumn 25, Issue 1, 2006, Pages 135-145

  Colognato, Renato ^a   Laurenza, Incoronata ^b   Fontana, Ilaria ^a   Coppedé, Fabio ^a   Siciliano, Gabriele ^d   Coecke, Sandra ^a   Aruoma, Okezie I ^c   Benzi, Luca ^b   Migliore, Lucia ^a  

^a UNIVERSITY OF PISA   (Italy)

^b Dipto di Endocrinologia Metabolismo Traumatologia e Medicina del Lavoro   (Italy)

^c JOINT RESEARCH CENTRE   (Italy)

^d LONDON SOUTH BANK UNIVERSITY   (United Kingdom)

Author keywords

Antioxidant; Ergothioneine; MAPKs; Neurodegenerative disorders; Oxidative stress; PC12

Indexed keywords

3 (4,5 DIMETHYL 2 THIAZOLYL) 2,5 DIPHENYLTETRAZOLIUM BROMIDE; HYDROGEN PEROXIDE; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE INHIBITOR; NATURAL PRODUCT; PROTEIN KINASE B; PROTEIN KINASE INHIBITOR; THIONEINE;

ANIMAL CELL; ANTIOXIDANT ACTIVITY; ARTICLE; CELL DEATH; CELL STRAIN; CELL VIABILITY; COMET ASSAY; CONCENTRATION RESPONSE; CONTROLLED STUDY; CORRELATION ANALYSIS; DNA DAMAGE; ENZYME ACTIVATION; FUNGUS; INCUBATION TIME; NERVE CELL; NONHUMAN; OXIDATION; PHEOCHROMOCYTOMA CELL; PROTEIN ANALYSIS; RAT; SOIL BACTERIUM;

ANIMALS; ANTIOXIDANTS; CELL DEATH; CELL SURVIVAL; COMET ASSAY; DNA DAMAGE; DOSE-RESPONSE RELATIONSHIP, DRUG; ERGOTHIONEINE; HYDROGEN PEROXIDE; IMMUNOBLOTTING; OXIDATION-REDUCTION; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PC12 CELLS; RATS; TIME FACTORS;

EID: 33144459831     PISSN: 02615614     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clnu.2005.10.005     Document Type: Article

References (51)

1. C.W. Olanow A radical hypothesis for neurodegeneration Trend Neurosci 16 2003 439-444
2. L. Migliore I. Fontana F. Trippi et. al. Oxidative DNA damage in peripheral leukocytes of Mild Cognitive Impairment and AD patients Neurobiol Aging 26 2005 567-573
3. M.D. Jacobson Reactive oxygen species and programmed cell death Trend Biochem Sci 21 1996 83-86
4. G. Deng J.H. Su K.J. Ivins B. Van Houten C.W. Cotman Bcl-2 facilitates recovery from DNA damage after oxidative stress Exp Neurol 159 1999 309-318
5. N.M. O'Brien J.A. Woods S.A. Aherne Y.C. O'Callaghan Cytotoxicity, genotoxicity and oxidative reactions in cellculture models: Modulatory effects of phytochemicals Biochem Soc Trans 28 2000 22-26
6. C. Behl Vitamin E protects neurons against oxidative cell death in vitro more effectively than 17-beta estradiol and induces the activity of the transcription factor NF-kappaB J Neural Transmiss 107 2000 393-407
7. H. Jang J K.J. Surh Protective effects of resveratrol on hydrogen peroxide-induced apoptosis in rat pheochromocytoma (PC12) cells Mutat Res 496 2001 181-190
8. M. Deiana A. Rosa V. Casu R. Piga M.A. Dessi Ergothioneine modulates oxidative damage in the kidney and liver of rats in vivo: Studies upon the profile of polyunsaturated fatty acids Clin Nutr 23 2004 183-193
9. I. Satoh N. Sakai Y. Enokido H. Uchiyama J. Hatanaka Free radical independent protection by nerve growth factor and Bcl-2 of PC12 cells from hydrogen peroxide triggered-apoptosis J Biochem 120 1996 540-546
10. A.K. Gorman A. McGowan C. O'Neill T. Cotter Oxidative stress and apoptosis in neurodegeneration J Neurol Sci 139 1996 45-52
11. A.M. Gardner F.H. Xu C. Fady et. al. Apoptotic versus nonapoptotic cytotoxicity induced by hydrogen peroxide Free Rad Biol Med 22 1997 73-83
12. O.I. Aruoma T. Bahorun L.S. Jen Neuroprotection by active components in medicinal and food plant extracts Mut Res Rev 544 2003 203-215
13. L. Migliore I. Fontana R. Colognato F. Coppede' G. Siciliano L. Murri Searching for the role and the proper biomarkers of oxidative stress in Alzheimer disease and in other neurodegenerative diseases Neurobiol Aging 26 2005 587-595
14. C. Yu M. Rahmani P. Dent S. Grant The hierarchical relationship between MAPK signalling and ROS generation in human leukaemia cells undergoing apoptosis in response to the proteasome inhibitor Bortezomib Exp Cell Res 295 2004 555-566
15. J.H. Je J.Y. Lee K.J. Jung et. al. NFκB activation mechanism of 4-hydroxyhexenal via NIK/IKK and p38 MAPK pathway FEBS Lett 566 2004 183-189
16. H. Mitsuyama J. May Uptake and antioxidant effects of ergothioneine in human erythrocytes Clin Sci 97 1999 407-411
17. J.A. Moncaster T.D. Walsh S.M. Gentleman L.S. Jen O.I. Aruoma Ergothioneine treatment protects neurons against N methyl-d-aspartate excitotoxicity in an in vivo rat retinal model Neurosci Lett 328 2002 55-59
18. D. Grundemann S. Harlfinger S. Golz et. al. Discovery of the ergothioneine transporter Proc Natl Acad Sci (USA) 102 2005 5256-5261
19. D.P. Hanlon Interaction of ergothioneine with metal ions and metalloenzymes J Med Chem 14 1971 1084-1087
20. O.I. Aruoma J.P.E. Spencer N. Mahmood Protection against oxidative damage and cell death by the natural antioxidant ergothioneine Food Chem Toxicol 37 1999 1043-1053
21. D. Akanmu R. Cecchini O.I. Aruoma B. Halliwell The antioxidant action of ergothioneine Arch Biochem Biophys 288 1991 10-16
22. O.I. Aruoma M. Whiteman G. England T B. Halliwell Antioxidant action of ergothioneine: Assessment of its ability to scavenge peroxynitrite Biochem Biophys Res Commun 231 1997 389-391
23. I. Rahman P.S. Gilmour L.A. Jimenez S.K. Biswas F. Antonicelli O.I. Aruoma Ergothioneine inhibits oxidative stress- and TNF-α-induced NF-κB activation and interleukin-8 release in alveolar epithelial cells Biochem Biophys Res Commun 302 2003 860-864
24. J.H. Jang O.I. Aruoma L.S. Jen H.Y. Chung Y.J. Surh Ergothioneine rescues PC12 cells form β-amyloid-induced apoptotic death Free Rad Biol Med 36 2004 288-299
25. L.A. Greene A.S. Tischler Establishment of a noradrenergic clonal line of rat adrenal pheochromocytoma cells which respond to nerve growth factor Proc Natl Acad Sci (USA) 73 1976 2424-2428
26. A. Collins M. Dusinskà C.M. Gedik R. Stetina Oxidative damage to DNA: Do we have a reliable biomarker? Environ Health Perspect 104 1996 465-469
27. K.Z. Guyton M. Gorospe N.J. Holbrook Oxidative stress and molecular biology of antioxidant defence 1997 Cold Spring Harbor Laboratory Press Cold Spring Harbor, NY
28. N.K. Fukagawa Aging: Is oxidative stress a marker or is it causal? Proc Soc Exp Biol Med 222 1999 293-298
29. M. Bilici H. Efe M.A. Koroglu H.A. Uydu M. Bekaroglu O. Deger Antioxidative enzyme activities and lipid peroxidation in major depression: Alteration by antidepressant treatments J Affective Dis 64 2001 43-51
30. J. Chandra A. Samali S. Orrenius Triggering and modulation of apoptosis by oxidative stress Free Rad Biol Med 29 2001 323-333
31. N. Jha J.K. Andersen The mechanism of action of the glutathione system in the protection of dopaminergic neurons S.G. Pandalai Involvement in Parkinson's disease, recent research development in neurochemistry 1999 99-108
32. B. Su M. Karin Mitogen-activated protein kinase cascades and regulation of gene expression Curr Opin Immunol 8 1996 402-441
33. H.J. Rhaese E. Freese Chemical analysis of DNA alterations I. Base liberation and backbone breakage of DNA and oligodeoxyadenylic acid induced by hydrogen peroxide and hydroxylamine Biochim Biophys Acta 155 1968 476-490
34. B. Halliwell O.I. Aruoma DNA damage by oxygen-derived species. Its mechanism and measurement in mammalian systems FEBS Lett 281 1991 9-19
35. O.I. Aruoma B. Halliwell DNA and free radicals: Techniques, mechanisms and applications 1998 London OICA International
36. P. De Meyts B. Wallach C.T. Christoffersen et. al. The insulin-like growth factor-I receptor. Structure, ligand-binding mechanism and signal transduction Horm Res 42 1994 152-169
37. J. Raingeaud S. Gupta J.S. Rogers et. al. Pro-inflammatory cytokines and environmental stress cause p38 mitogen-activated protein kinase activation by dual phosphorylation on tyrosine and threonine J Biol Chem 270 1995 7420-7426
38. Y.R. Chen C.F. Meyer T.H. Tan Persistent activation of c-Jun N-terminal kinase 1 (JNK1) in gamma radiation-induced apoptosis J Biol Chem 271 1996 631-634
39. D. Callsen B. Brune Role of mitogen-activated protein kinases in S-nitrosoglutathione-induced macrophage apoptosis Biochemistry 38 1999 2279-2286
40. K.P. Sarker M. Nakata I. Kitajima T. Nakajima I. Maruyama Inhibition of caspase-3 activation by SB203580, p38 mitogen-activated protein kinase inhibitor in nitric oxide-induced apoptosis of PC-12 cells J Mol Neurosci 15 2000 243-250
41. J. Han J.D. Lee L. Bibbs R.J. Ulevitch A MAP kinase targeted by endotoxin and hyperosmolarity in mammalian cells Science 265 1994 808-811
42. J. Rouse P. Cohen S. Trigon et. al. A novel kinase cascade triggered by stress and heat shock that stimulates MAPKAP kinase-2 and phosphorylation of the small heat shock proteins Cell 23 1994 1027-1037
43. G.V. Johnson C.D. Bailey The p38 MAP kinase signaling pathway in Alzheimer's disease Exp Neurol 183 2003 263-268
44. E. Hollenbach M. Neumann M. Vieth A. Roessner P. Malfertheiner M. Naumann Inhibition of p38 MAP kinase- and RICK/NF-kappaB-signaling suppresses inflammatory bowel disease FASEB J 18 2004 1550-1552
45. D.G. Perregaux D. Dean M. Cronan P. Connelly C.A. Gabel Inhibition of interleukin-1 beta production by SKF86002: Evidence of two sites of in vitro activity and of a time and system dependence Mol Pharmacol 48 1995 433-442
46. P.J. Crack J.M. Taylor Reactive oxygen species and the modulation of stroke Free Rad Biol Med 38 2005 1433-1444
47. M.E. Noble J.A. Endicott L.N. Johnson Protein kinase inhibitors: insights into drug design from structure Science 303 2004 1800-1805
48. S. Boldt W. Kolch Targeting MAPK signalling: Prometheus' fire or Pandora's box? Curr Pharm Des 10 2004 1885-1905
49. J. Morel F. Berenbaum Signal transduction pathways: New targets for treating rheumatoid arthritis Joint Bone Spine 71 2004 503-510
50. P.J. Barnes New treatments for chronic obstructive pulmonary disease Ann Ist Super Sanita 39 2003 573-582
51. Y. Liao M.C. Hung A new role of protein phosphatase 2a in adenoviral E1A protein-mediated sensitization to anticancer drug-induced apoptosis in human breast cancer cells Cancer Res 64 2004 5938-5942